Vir Biotec and Alnylam expanded collaboration to advance RNAi therapeutics for reatment of Coronavirus Infection
On Mar. 4, 2020, Vir Biotech and Alnylam Pharmaceuticals announced an expansion of their existing collaboration to include…
Novavax advanced development of novel COVID-19 vaccine
On Feb. 26, 2020, Novavax announced progress in its efforts to develop a novel vaccine to protect against…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
New technique helped uncover how Coronaviruses enter cells
On Feb. 24, 2020, researchers at National Institute of Allergy and Infectious Disease’s Rocky Mountain Laboratories in Hamilton,…
Moderna shipped mRNA vaccine against novel Coronavirus (mRNA-1273) for phase 1 study
On Feb. 24, 2020, Moderna announced it had released the first batch of mRNA-1273, the Company’s vaccine against…
FDA approved Fluad Quadrivalent (influenza vaccine, adjuvanted; Seqirus) for adults 65 years and older
On Feb. 24, 2020, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved the first…
Sanofi joined with U.S. Dept of Health and Human Services to advance novel coronavirus vaccine
On Feb. 18, 2020, Sanofi announced it had leveraged previous development work for a SARS vaccine which may…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Therapeutics | Vaccine | Women's Health
Sorrento and Celularity to initiate emergency allogeneic natural killer cell therapy development for Coronavirus infection
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
Cases of pneumonia detected in Wuhan, China were first reported to the WHO
On Dec. 31, 2019, the World Health Organization (WHO) declared the Coronavirus outbreak a global pandemic. To date,…
Seqirus’ Received Health Canada approval of first cell-based seasonal influenza vaccine
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
Biotechnology | Diagnostics | Genomics | HIV | Infectious Disease | Life Science News | Therapeutics
Abbott announced discovery of a new strain of HIV
On Nov. 6, 2019, Abbott announced that a team of its scientists identified a new subtype of the…
Genentech announced FDA approval of antiviral drug Xofluza (Baloxavir Marboxil)
On Oct. 17, 2019, Genentech announced the U.S. Food and Drug Administration (FDA) had approved Xofluza (Baloxavir Marboxil),…
Biotechnology | Infectious Disease | Life Science News | NIH | Non-Profit Research | Therapeutics | Vaccine
Seattle Children’s received $30 million NIH funding to establish centers for TB vaccine development
On Sept. 26, 2019, Seattle Children’s announced it was one of three recipients of $30 million in first-year-funding…
Biotechnology | CDC | Infectious Disease | Influenza | Life Science News | Non-Profit Research | Vaccine
CDC released ACIP recommendations on use of influenza vaccines for the 2019-20 influenza season
On Aug. 23, 2019, the Centers for Disease Control and Prevention (CDC) released Immunization Practices Advisory Committee (ACIP)…
GSK invested $100 million to expand long-term vaccine manufacturing capabilities in Hamilton
On Apr. 24, 2019, GSK announced $100 million of new investment in its manufacturing site in Hamilton, Montana…
Sinovac announced positive results from phase III trial of a Sabin strain-based inactivated Polio vaccine (sIPV) were published
On Apr. 16, 2019, Sinovac Biotech announced that the positive results from the Company’s Phase III clinical study…
FDA approved Vaxelis, a new combination DTaP-IPV-Hib-HepB vaccine for use in children 6 wks-4 yrs of age
On Dec. 26, 2018, Sanofi announced the U.S. Food and Drug Administration (FDA) had approved VAXELIS (Diphtheria and…
Seqirus’ Next Generation Cell-based Influenza Vaccine Shows Significantly Greater Effectiveness Compared to Standard Egg-based Options in the 2017-18 US Influenza Season
On Dec. 5, 2018, Seqirus, a CSL subsidiary, announced real-world data showing that its cell-based quadrivalent influenza vaccine…
Genomic analysis offered insight into 2018 Nigeria Lassa fever outbreak
On Oct. 18, 2018, an international team of researchers reported that a surge in Lassa fever cases in…
The American College of Obstetricians and Gynecologists issued a committee opinion on maternal immunization
On Jun. 1, 2018, the American College of Obstetricians and Gynecologists (ACOG) issued a committee opinion on maternal…
WHO recommended use of first typhoid conjugate vaccine
On Apr. 3, 2018, the World Health Organization (WHO) recommended the introduction of typhoid conjugate vaccine (TCV) for…
CDC published updated ACIP recommendations for prevention of hepatitis B virus infection
On Jan. 12, 2018, the U.S. Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory…
Biotechnology | CDC | Diagnostics | FDA | Infectious Disease | Influenza | Life Science News | U.S. Congress | Vaccine | Veterinary
Experts decried lack of flu pandemic readiness, commitment
On Jan. 9, 2018, armed with 1940s-vintage flu vaccine technology and supported by only anemic funding for developing…
Seqirus announced major advances in pandemic preparedness
On Aug. 7, 2017, Seqirus announced that the accelerated development of cell-based manufacturing technology at its state-of-the-art manufacturing…
Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | NIH | Non-Profit Research | Vaccine | Veterinary
HHS Influenza Pandemic Planning Update was published
On Jun. 15, 2017, the U.S. Department of Health and Human Services (HHS) published the nations’s updated Pandemic…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Life Science News | USDA | Veterinary
Screwworm eradicated in Florida, again
On April 26, 2017, the U.S. Department of Agriculture’s (USDA) announced that the New World screwworm (NWS) had…
Biotechnology | Disease | Infectious Disease | Influenza | Life Science News | Non-Profit Research | Therapeutics | Vaccine
CDC updated guidelines for use of non-pharmaceutical measures to help prevent spread of pandemic influenza
On Apr. 21, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published updated guidelines for use…
CDC published the 2017 US recommended immunization schedules for 0 through 18 years
On Feb. 10, 2017, the Advisory Committee on Immunization Practices (ACIP) approved the Recommended Immunization Schedule for Children…
CDC published the 2017 U.S. recommended adult immunization schedule
On Feb. 10, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published the 2017 U.S. recommended…
FDA approved extending the age range for use of FluLaval Quadrivalent to include children 6 to 35 months of age
On Nov. 18, 2016, the U.S. Food and Drug Administration (FDA) approved extending the age range for use…
Artificial Intelligence | Biotechnology | Disease | Genomics | Infectious Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
Washington University invested $25 million in imaging sciences
On Nov. 18, 2016, Washington University in St. Louis launched a bold, $25 million initiative over the next…